醫渡科技(02158.HK)年度收入8.67億元 同比增加55.4%
格隆匯6月25日丨醫渡科技(02158.HK)公告,截至2021年3月31日止財政年度的年度業績,公司實現收入8.67億元,同比增加55.4%;毛利3.27億元,同比增加123.4%;董事會不建議分派截至2021年3月31日止財政年度的末期股息。
截至2020年3月31日財政年度,儘管存在外部壓力,但公司的業務仍保持強勁增長。報告期間,公司不斷夯實醫療大數據基建YiduCore,同時通過現有客戶和新客戶大力拓展建立在YiduCore上的新型業務。公司的總收入達到人民幣8.67億元,同比增長55.4%。公司的毛利率爲37.8%,同比提升11.5個百分點。
截至2021年3月31日,公司已經向76家中國頂級研究型醫院、19個監管機構和政策制定者提供瞭解決方案服務,較去年同期增加5家醫院和5個監管機構和政策制定者。集團服務的生命科學解決方案的客戶數量在2021年3月31日達到108家,較2020年3月31日的74家增加34家。
醫療大數據基建YiduCore能夠支持公司的客戶和合作夥伴以安全合規的方式實現高質量數據在不同場景下的應用,從而釋放數據的價值。以上能夠實現都得益於公司對"數據智能,綠色醫療"的堅持和多年來的持續投資。
作爲中國領先的醫療大數據解決方案提供者,公司秉承"使價值導向的精準醫療惠及每一個人"的使命,以期爲醫療生態圈的主要參與者1帶來更大的價值並最終爲患者提供更好的服務和效果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.